StockCIK 1802369
ADARx Pharmaceuticals, Inc. (ADRX): Insider Trades and Fund Holdings
In the past 12 months, ADARx Pharmaceuticals, Inc. insiders reported 5 open-market purchases worth $87.7M and 0 sales worth $0.
5Insider buys, 12 months
$87.7MBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 30, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 30 | Orbimed Advisors LLCDirector | ▲ BUY | $16.1M |
| Sep 30 | Carl L. GordonDirector | ▲ BUY | $16.1M |
| Sep 30 | Erez ChimovitsDirector | ▲ BUY | $1.05M |
| Sep 29 | Simeon GeorgeDirector | ▲ BUY | $27.2M |
| Sep 29 | Sr One Capital Management, LLC10% owner | ▲ BUY | $27.2M |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | Director | 1 | $16.1M | 0 | $0 |
| Carl L. Gordon | Director | 1 | $16.1M | 0 | $0 |
| Erez Chimovits | Director | 1 | $1.05M | 0 | $0 |
| Simeon George | Director | 1 | $27.2M | 0 | $0 |
| Sr One Capital Management, LLC | 10% owner | 1 | $27.2M | 0 | $0 |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →